Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-05 4:30 pm Purchase | 2022-11-23 | 13G | OptiNose, Inc. OPTN | ACORN BIOVENTURES L.P. | 757,931 9.900% | 757,931 (New Position) | Filing History |
| 2021-02-12 4:58 pm Purchase | 2020-12-18 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | ACORN BIOVENTURES L.P. | 156,299 9.990% | 156,299 (New Position) | Filing History |
| 2020-07-02 2:59 pm Purchase | 2020-06-15 | 13D | Cardiff Oncology, Inc. CRDF | ACORN BIOVENTURES L.P. | 5,990,839 9.990% | 4,303,279 (+255.00%) | Filing History |
| 2020-06-04 4:14 pm Purchase | 2020-05-27 | 13G | Cardiff Oncology, Inc. CRDF | ACORN BIOVENTURES L.P. | 1,687,560 9.990% | 1,687,560 (New Position) | Filing History |